- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Showing 13–24 of 78 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PlGF , VEGF-A , VEGF-B |
Fusion protein |
Zaltrap® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
EGFR , MET |
Bispecific Antibody |
Rybrevant® |
50 mg/ml |
– |
7 mg |
-80°C |
tba |
356,00 € |
||
VEGF-A |
Monoclonal Antibody |
Zirabev® |
25 mg/mL |
– |
2 mg |
tba |
tba |
200,00 € |
||
VEGF-A |
Monoclonal Antibody |
Oyavas® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Alymsys® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Aybintio® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Abevmy® |
25 mg/mL |
– |
2 mg |
tba |
tba |
207,00 € |
||
VEGF-A |
Monoclonal Antibody |
Vegzelma® |
25 mg/mL |
– |
2 mg |
tba |
tba |
198,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
06/2018 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
09/2018 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
09/2018 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
12/2018 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
03/2019 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
10/2019 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
03/2021 |
185,40 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
09/2017 |
233,10 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
03/2018 |
233,10 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
12.5 mg |
-80°C |
06/2024 |
443,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
07/2024 |
206,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
2 mg |
-80°C |
tba |
785,00 € |
||
PD-1 |
Monoclonal Antibody |
Libtayo® |
50 mg/mL |
– |
5 mg |
tba |
tba |
569,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
169,20 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
01/2020 |
169,20 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
05/2021 |
169,20 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
5 mg |
-80°C |
09/2021 |
160,20 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
11/2021 |
169,20 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
5 mg |
-80°C |
07/2027 |
319,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
08/2024 |
1.127,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
03/2025 |
1.127,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin